Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions ; volume:13 ; number:1 ; day:11 ; month:11 ; year:2020 ; pages:1-5 ; date:12.2020
Journal of hematology & oncology ; 13, Heft 1 (11.11.2020), 1-5, 12.2020
- Urheber
-
Zhang, Li
Tian, Lin
Dai, Xiaoyang
Yu, Hua
Wang, Jiajia
Lei, Anhua
Zhu, Mengmeng
Xu, Jianpo
Zhao, Wei
Zhu, Yuqing
Sun, Zhen
Zhang, Hao
Hu, Yongxian
Wang, Yanlin
Xu, Yuming
Church, George M.
Huang, He
Weng, Qinjie
Zhang, Jin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-020-00983-2
- URN
-
urn:nbn:de:101:1-2020122219242987085836
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Li
- Tian, Lin
- Dai, Xiaoyang
- Yu, Hua
- Wang, Jiajia
- Lei, Anhua
- Zhu, Mengmeng
- Xu, Jianpo
- Zhao, Wei
- Zhu, Yuqing
- Sun, Zhen
- Zhang, Hao
- Hu, Yongxian
- Wang, Yanlin
- Xu, Yuming
- Church, George M.
- Huang, He
- Weng, Qinjie
- Zhang, Jin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Engineering better chimeric antigen receptor T cells
scMAGeCK links genotypes with multiple phenotypes in single-cell CRISPR screens
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing
Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Engineering better chimeric antigen receptor T cells
scMAGeCK links genotypes with multiple phenotypes in single-cell CRISPR screens
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing
Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database
Special issue: CAR‐T cell therapy for hematological malignancies
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Engineering better chimeric antigen receptor T cells
scMAGeCK links genotypes with multiple phenotypes in single-cell CRISPR screens
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing